Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Pharma (IGC) over the last 16 years, with Q1 2025 value amounting to $16000.0.

  • Pharma's Other Non-Current Liabilities fell 2000.0% to $16000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $16000.0, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of $16000.0 for FY2025, which is 2000.0% down from last year.
  • Per Pharma's latest filing, its Other Non-Current Liabilities stood at $16000.0 for Q1 2025, which was down 2000.0% from $16000.0 recorded in Q4 2024.
  • In the past 5 years, Pharma's Other Non-Current Liabilities registered a high of $21000.0 during Q1 2023, and its lowest value of $15000.0 during Q1 2021.
  • Over the past 5 years, Pharma's median Other Non-Current Liabilities value was $16000.0 (recorded in 2022), while the average stood at $17058.8.
  • Per our database at Business Quant, Pharma's Other Non-Current Liabilities surged by 3125.0% in 2023 and then crashed by 2000.0% in 2025.
  • Over the past 5 years, Pharma's Other Non-Current Liabilities (Quarter) stood at $15000.0 in 2021, then changed by 0.0% to $15000.0 in 2022, then grew by 13.33% to $17000.0 in 2023, then decreased by 5.88% to $16000.0 in 2024, then changed by 0.0% to $16000.0 in 2025.
  • Its last three reported values are $16000.0 in Q1 2025, $16000.0 for Q4 2024, and $20000.0 during Q3 2024.